<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03604523</url>
  </required_header>
  <id_info>
    <org_study_id>H00004174</org_study_id>
    <nct_id>NCT03604523</nct_id>
  </id_info>
  <brief_title>Esophageal Dysmotility - Prospective Study Evaluating Methods for Esophageal Dilation</brief_title>
  <official_title>Effectiveness of Semi-rigid Savary Dilators vs. Balloon Dilators During Esophageal Dilation in the Treatment of Esophageal Dysmotility</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Massachusetts, Worcester</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Massachusetts, Worcester</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to prospectively evaluate the most effective treatment of&#xD;
      esophageal dysmotility that alleviates symptoms of dysphagia and improves quality of life.&#xD;
&#xD;
      Current practice uses either semi-rigid Savary dilators or balloon dilators for esophageal&#xD;
      dilation to treat dysphagia due to esophageal dysmotility. The study aims to show which&#xD;
      treatment method is more effective in alleviating symptoms, since there are no other&#xD;
      treatments available. The null hypothesis is that there is no difference between the clinical&#xD;
      benefits of each treatment.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Both the Savary and balloon dilators are used as routine procedure at University of&#xD;
      Massachusetts (UMass) Medical School's academic medical center UMass Memorial Health Care&#xD;
      (UMMHC). Gastroenterologists are required as part of their training to be familiar with both&#xD;
      types of procedures. This study aims to definitively determine which treatment method is more&#xD;
      effective in alleviating the symptoms of esophageal dysmotility.&#xD;
&#xD;
      The primary clinical endpoint is to assess the therapeutic efficacy of different types of&#xD;
      dilators in an esophageal dilation procedure in patients with esophageal dysmotility. This&#xD;
      will be evaluated through the use of the dysphagia scale (Knyrim et al, 1993). The secondary&#xD;
      aims are to assess time to relapse, diet improvement, as well as change in quality of life.&#xD;
      Investigators will determine time to relapse by time between the dilation procedures.&#xD;
      Participants are instructed to contact the GI office to schedule another dilation if they&#xD;
      feel as though the therapeutic effect of the procedure has subsided and they are in need of&#xD;
      additional relief. Diet will be assessed using the diet score (Cox et al, 1998) and quality&#xD;
      of life will be assessed using the Short Form (SF) SF-12 Health Survey.&#xD;
&#xD;
      If patients fail the first procedure, they can be offered the alternative procedure at a&#xD;
      later date. Both the patient and physician must agree that the treatment has not worked, and&#xD;
      then the patient will be given the opportunity to cross over to the other procedure, still&#xD;
      blinded to the device that will be used. Investigators will conduct an interim evaluation to&#xD;
      assess the progress of the study and degree of crossover. This will ensure that all subjects&#xD;
      are given the opportunity to have both devices used in the event that one is significantly&#xD;
      superior to the other.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Slow enrollment&#xD;
  </why_stopped>
  <start_date type="Actual">August 14, 2014</start_date>
  <completion_date type="Actual">November 26, 2016</completion_date>
  <primary_completion_date type="Actual">November 26, 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Participants are randomized to procedure, but if participant fails the first procedure they are given the opportunity to crossover to the other arm for a follow up procedure.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Therapeutic Efficacy as Measured by Change in Dysphagia Scale Score</measure>
    <time_frame>Baseline to 6 months post-procedure</time_frame>
    <description>Therapeutic efficacy of different types of dilators in an esophageal dilation procedure in patients with esophageal dysmotility. This will be evaluated through the use of the dysphagia scale (Knyrim 1993). Minimum score is 0. Maximum score is 4. Higher scores indicate a worse outcome. The data presented represent a change from baseline to 6 months calculated as the value at 6 months minus the value at baseline.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Participants With Relapse</measure>
    <time_frame>Baseline to 6 months</time_frame>
    <description>Participants who required esophageal dilation within time frame</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to Relapse</measure>
    <time_frame>Initial intervention to second dilation</time_frame>
    <description>For the participants who relapsed, measure of time to relapse based on time from procedure to need for additional dilation due to subsidence of therapeutic effect of procedure.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diet Dysphagia Score Change</measure>
    <time_frame>baseline to 6 months post procedure</time_frame>
    <description>Diet dysphagia score change based on change to Cox diet score, taken from Table 1 of publication Gut, 1988, 29, 1741-1747. The scores are determined based on the foods that cause dysphagia. The minimum value on the score is 0 (no dysphagia), followed by 1 (dysphagia with meat), 2 (dysphagia with bread), 3 (dysphagia with semi-solids), 4 (dysphagia with liquids), and the maximum score is 5 (total dysphagia). A higher score indicates a worse clinical outcome. The data presented represent a change from baseline to 6 months calculated as the value at 6 months minus the value at baseline</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">10</enrollment>
  <condition>Esophageal Dysmotility</condition>
  <arm_group>
    <arm_group_label>Dilation by Balloon</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Esophageal dilation by balloon device.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dilation by Semi-rigid Savary</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Esophageal dilation by semi-rigid savary device.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Dilation by Balloon</intervention_name>
    <description>Esophageal dilation by balloon device.</description>
    <arm_group_label>Dilation by Balloon</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Dilation by Semi-rigid Savary</intervention_name>
    <description>Esophageal dilation by semi-rigid savary device</description>
    <arm_group_label>Dilation by Semi-rigid Savary</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  &gt; 18 years old&#xD;
&#xD;
          -  Dysphagia to liquids and/or solids&#xD;
&#xD;
          -  Diagnosis of esophageal dysmotility&#xD;
&#xD;
          -  Normal endoscopic exam&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Diagnosis of achalasia&#xD;
&#xD;
          -  Defined strictures or webs&#xD;
&#xD;
          -  Vulnerable populations:&#xD;
&#xD;
          -  Adults unable to consent (Individuals who are not yet adults (infants, children,&#xD;
             teenagers), Pregnant women, Prisoners)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>David Cave, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Professor of Medicine, UMass Medical School</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UMass Memorial Medical Center</name>
      <address>
        <city>Worcester</city>
        <state>Massachusetts</state>
        <zip>01655</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>June 26, 2018</study_first_submitted>
  <study_first_submitted_qc>July 19, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">July 27, 2018</study_first_posted>
  <results_first_submitted>February 17, 2021</results_first_submitted>
  <results_first_submitted_qc>March 18, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">April 13, 2021</results_first_posted>
  <last_update_submitted>March 18, 2021</last_update_submitted>
  <last_update_submitted_qc>March 18, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 13, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Massachusetts, Worcester</investigator_affiliation>
    <investigator_full_name>David Cave</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Esophageal Motility Disorders</mesh_term>
    <mesh_term>Esophageal Spasm, Diffuse</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Dilation by Balloon</title>
          <description>Esophageal dilation by balloon device.&#xD;
Dilation by Balloon: Esophageal dilation by balloon device.</description>
        </group>
        <group group_id="P2">
          <title>Dilation by Semi-rigid Savary</title>
          <description>Esophageal dilation by semi-rigid savary device.&#xD;
Dilation by Semi-rigid Savary: Esophageal dilation by semi-rigid savary device</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="5"/>
                <participants group_id="P2" count="5"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="5"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Dilation by Balloon</title>
          <description>Esophageal dilation by balloon device.&#xD;
Dilation by Balloon: Esophageal dilation by balloon device.</description>
        </group>
        <group group_id="B2">
          <title>Dilation by Semi-rigid Savary</title>
          <description>Esophageal dilation by semi-rigid savary device.&#xD;
Dilation by Semi-rigid Savary: Esophageal dilation by semi-rigid savary device</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="5"/>
            <count group_id="B2" value="5"/>
            <count group_id="B3" value="10"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="2"/>
                    <measurement group_id="B3" value="6"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="66" lower_limit="52" upper_limit="78"/>
                    <measurement group_id="B2" value="56.8" lower_limit="45" upper_limit="68"/>
                    <measurement group_id="B3" value="61.4" lower_limit="45" upper_limit="78"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="8"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B2" value="1"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="5"/>
                    <measurement group_id="B2" value="5"/>
                    <measurement group_id="B3" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Therapeutic Efficacy as Measured by Change in Dysphagia Scale Score</title>
        <description>Therapeutic efficacy of different types of dilators in an esophageal dilation procedure in patients with esophageal dysmotility. This will be evaluated through the use of the dysphagia scale (Knyrim 1993). Minimum score is 0. Maximum score is 4. Higher scores indicate a worse outcome. The data presented represent a change from baseline to 6 months calculated as the value at 6 months minus the value at baseline.</description>
        <time_frame>Baseline to 6 months post-procedure</time_frame>
        <population>Data missing from participants who were lost to follow up at 6 months. Data provided for participants who completed 6 month follow up dysphagia score assessment.</population>
        <group_list>
          <group group_id="O1">
            <title>Dilation by Balloon</title>
            <description>Esophageal dilation by balloon device.&#xD;
Dilation by Balloon: Esophageal dilation by balloon device.</description>
          </group>
          <group group_id="O2">
            <title>Dilation by Semi-rigid Savary</title>
            <description>Esophageal dilation by semi-rigid savary device.&#xD;
Dilation by Semi-rigid Savary: Esophageal dilation by semi-rigid savary device</description>
          </group>
        </group_list>
        <measure>
          <title>Therapeutic Efficacy as Measured by Change in Dysphagia Scale Score</title>
          <description>Therapeutic efficacy of different types of dilators in an esophageal dilation procedure in patients with esophageal dysmotility. This will be evaluated through the use of the dysphagia scale (Knyrim 1993). Minimum score is 0. Maximum score is 4. Higher scores indicate a worse outcome. The data presented represent a change from baseline to 6 months calculated as the value at 6 months minus the value at baseline.</description>
          <population>Data missing from participants who were lost to follow up at 6 months. Data provided for participants who completed 6 month follow up dysphagia score assessment.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="3"/>
                <count group_id="O2" value="4"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-1" lower_limit="-2" upper_limit="0"/>
                    <measurement group_id="O2" value="-0.25" lower_limit="-1" upper_limit="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Participants With Relapse</title>
        <description>Participants who required esophageal dilation within time frame</description>
        <time_frame>Baseline to 6 months</time_frame>
        <population>The population of those who were enrolled in the arms and received the assigned intervention.</population>
        <group_list>
          <group group_id="O1">
            <title>Dilation by Balloon</title>
            <description>Esophageal dilation by balloon device.&#xD;
Dilation by Balloon: Esophageal dilation by balloon device.</description>
          </group>
          <group group_id="O2">
            <title>Dilation by Semi-rigid Savary</title>
            <description>Esophageal dilation by semi-rigid savary device.&#xD;
Dilation by Semi-rigid Savary: Esophageal dilation by semi-rigid savary device</description>
          </group>
        </group_list>
        <measure>
          <title>Participants With Relapse</title>
          <description>Participants who required esophageal dilation within time frame</description>
          <population>The population of those who were enrolled in the arms and received the assigned intervention.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="4"/>
                <count group_id="O2" value="5"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Time to Relapse</title>
        <description>For the participants who relapsed, measure of time to relapse based on time from procedure to need for additional dilation due to subsidence of therapeutic effect of procedure.</description>
        <time_frame>Initial intervention to second dilation</time_frame>
        <population>Participants who experienced a relapse in time period from baseline to 6 months. Only 2 participants in the dilation by balloon group experienced a relapse. This population was used to calculate the time to relapse. No participants in the dilation by semi-rigid Savary experienced a relapse during this time.</population>
        <group_list>
          <group group_id="O1">
            <title>Dilation by Balloon</title>
            <description>Esophageal dilation by balloon device.&#xD;
Dilation by Balloon: Esophageal dilation by balloon device.</description>
          </group>
          <group group_id="O2">
            <title>Dilation by Semi-rigid Savary</title>
            <description>Esophageal dilation by semi-rigid savary device.&#xD;
Dilation by Semi-rigid Savary: Esophageal dilation by semi-rigid savary device</description>
          </group>
        </group_list>
        <measure>
          <title>Time to Relapse</title>
          <description>For the participants who relapsed, measure of time to relapse based on time from procedure to need for additional dilation due to subsidence of therapeutic effect of procedure.</description>
          <population>Participants who experienced a relapse in time period from baseline to 6 months. Only 2 participants in the dilation by balloon group experienced a relapse. This population was used to calculate the time to relapse. No participants in the dilation by semi-rigid Savary experienced a relapse during this time.</population>
          <units>days</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="2"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="72" lower_limit="27" upper_limit="117"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Diet Dysphagia Score Change</title>
        <description>Diet dysphagia score change based on change to Cox diet score, taken from Table 1 of publication Gut, 1988, 29, 1741-1747. The scores are determined based on the foods that cause dysphagia. The minimum value on the score is 0 (no dysphagia), followed by 1 (dysphagia with meat), 2 (dysphagia with bread), 3 (dysphagia with semi-solids), 4 (dysphagia with liquids), and the maximum score is 5 (total dysphagia). A higher score indicates a worse clinical outcome. The data presented represent a change from baseline to 6 months calculated as the value at 6 months minus the value at baseline</description>
        <time_frame>baseline to 6 months post procedure</time_frame>
        <population>Data is incomplete. Only 1 participant provided full diet score survey at 6 months.</population>
        <group_list>
          <group group_id="O1">
            <title>Dilation by Balloon</title>
            <description>Esophageal dilation by balloon device.&#xD;
Dilation by Balloon: Esophageal dilation by balloon device.</description>
          </group>
          <group group_id="O2">
            <title>Dilation by Semi-rigid Savary</title>
            <description>Esophageal dilation by semi-rigid savary device.&#xD;
Dilation by Semi-rigid Savary: Esophageal dilation by semi-rigid savary device</description>
          </group>
        </group_list>
        <measure>
          <title>Diet Dysphagia Score Change</title>
          <description>Diet dysphagia score change based on change to Cox diet score, taken from Table 1 of publication Gut, 1988, 29, 1741-1747. The scores are determined based on the foods that cause dysphagia. The minimum value on the score is 0 (no dysphagia), followed by 1 (dysphagia with meat), 2 (dysphagia with bread), 3 (dysphagia with semi-solids), 4 (dysphagia with liquids), and the maximum score is 5 (total dysphagia). A higher score indicates a worse clinical outcome. The data presented represent a change from baseline to 6 months calculated as the value at 6 months minus the value at baseline</description>
          <population>Data is incomplete. Only 1 participant provided full diet score survey at 6 months.</population>
          <units>units on a scale</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="1"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Baseline to 6 months after procedure</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Dilation by Balloon</title>
          <description>Esophageal dilation by balloon device.&#xD;
Dilation by Balloon: Esophageal dilation by balloon device.</description>
        </group>
        <group group_id="E2">
          <title>Dilation by Semi-rigid Savary</title>
          <description>Esophageal dilation by semi-rigid savary device.&#xD;
Dilation by Semi-rigid Savary: Esophageal dilation by semi-rigid savary device</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Nervous system disorders</title>
            <event_list>
              <event>
                <sub_title>Migraine</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Respiratory, thoracic and mediastinal disorders</title>
            <event_list>
              <event>
                <sub_title>Shortness of breath</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="4" subjects_at_risk="4"/>
                <counts group_id="E2" subjects_affected="5" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Dysphagia</sub_title>
                <counts group_id="E1" events="3" subjects_affected="3" subjects_at_risk="4"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Dyspepsia</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>General disorders</title>
            <event_list>
              <event>
                <sub_title>Chest pain</sub_title>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="4"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Musculoskeletal and connective tissue disorders</title>
            <event_list>
              <event>
                <sub_title>Joint pain</sub_title>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="4"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Leg cramps</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5"/>
              </event>
              <event>
                <sub_title>Leg pain</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="4"/>
                <counts group_id="E2" events="1" subjects_affected="1" subjects_at_risk="5"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Recruitment was much slower than planned and the study was terminated early with only 15.6% of overall study goal enrolled. Early termination led to small numbers of subjects analyzed. Subjects unable to be reached for followup led to missing data for outcome measures.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr. David Cave</name_or_title>
      <organization>UMass Medical School</organization>
      <phone>508-856-8399</phone>
      <email>david.cave@umassmemorial.org</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

